Stay updated on Efficacy of MTPS9579A in Asthma Patients: Clinical Trial

Sign up to get notified when there's something new on the Efficacy of MTPS9579A in Asthma Patients: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy of MTPS9579A in Asthma Patients: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy, safety, and pharmacokinetics evaluation of MTPS9579A as an add-on therapy in patients with uncontrolled moderate to severe asthma requiring inhaled corticosteroids and a second controller medication.
    Difference
    0.1%
    Check dated 2024-06-06T14:38:58.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying requirements such as documented physician-diagnosed asthma and treatment history. Previously, this section had no information provided.
    Difference
    24%
    Check dated 2024-05-22T21:20:17.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:28:54.000Z thumbnail image

Stay in the know with updates to Efficacy of MTPS9579A in Asthma Patients: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy of MTPS9579A in Asthma Patients: Clinical Trial page.